Brief: Irlab Therapeutics Q2 Operating Loss Widens To SEK 30.4 Mln

IRLAB Therapeutics AB

28/08/2019 07:54

Aug 28 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * Q2 OPERATING LOSS SEK 30.4 MILLION VERSUS LOSS SEK 23.5
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkrcdX2Mc 
Further company coverage:  IRLABa.ST 

 (Reporting by Aleksandra Jasiurska)
 ((Aleksandra.Jasiurska@thomsonreuters.com;))